Novavax combined influenza/Covid-19 vaccine shows promise in preclinical study
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Novavax logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Novavax Inc said on Monday its combined flu and Covid-19 vaccine produced functional antibodies against influenza and the coronavirus in a preclinical study
Keep updated, follow The Business Standard's Google news channel
